Primary record
(2S)-2-((4-((4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl)-9-oxa-3,6-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),2,4,10,12-pentaen-12-yl)amino)propanamide
- 库存
- 4,120 克
- 纯度
- 98.7 %
- CAS
- 2060571-02-8
化合物标识与属性
- CAS
- 2060571-02-8
- PubChem CID
- 124173720
- SMILES
- C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](COC4=O)C(F)F
- Canonical SMILES
- C[C@H](Nc1ccc2c(c1)OCCn1cc(N3C(=O)OC[C@H]3C(F)F)nc1-2)C(N)=O
名称与同义词
- Inavolisib
- GDC-0077
- Itovebi
- 2060571-02-8
- Inavolisib [USAN]
- Itovebi (TN)
- L4C1UY2NYH
- GDC0077
- RG6114
- INAVOLISIB [INN]
- Inavolisib (USAN/INN)
- RefChem:148062
- UNII-L4C1UY2NYH
- Ro7113755
- INAVOLISIB [WHO-DD]
- MFCD31382124
- PI3K Inhibitor GDC0077
- SGEUNORSOZVTOL-CABZTGNLSA-N
- GTPL9636
- orb1308276
- CHEMBL4650215
- GDC 0077
- SCHEMBL18360780
- SCHEMBL29695471
- RG-6114
- C18H19F2N5O4
- BDBM295665
- DTXSID101358744
- GLXC-24203
- AMY16810
- EX-A2685
- RG 6114
- GDC-0077?
- NSC800729
- s8668
- US10112932, Compound 101
- WHO 11204
- RO-7113755
- AKOS040741785
- ZINC669678973
- ACN-053209
- AT36699
- CS-6459
- DB15275
- GDC-0077; RG6114
- NSC-800729
- AC-31594
- BP-43656
- MS-26989
- SY235756
- HY-101562
- RO 7113755
- D11942
- A903455
- (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide
- GDC-0077;RG6114;RO-7113755
- (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
- B2693-007357
- (2S)-2-[[2-[(4S)-4-(Difluoromethyl)-2-oxo-3-oxazolidinyl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
- N~2~-{(4S,11aP)-2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-L-alaninamide
- Propanamide, 2-((2-((4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl)-5,6-dihydroimidazo(1,2-d)(1,4)benzoxazepin-9-yl)amino)-, (2S)-
- (2S)-2-((2-((4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl)-5,6-dihydroimidazo(1,2-d)(1,4)benzoxazepin-9-yl)amino)propanamide
- (2S)-2-((2-((4S)-4-(DIFLUOROMETHYL)-2-OXO-3-OXAZOLIDINYL)-5,6-DIHYDROIMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)AMINO)PROPANAMIDE
- (2S)-2-((4-((4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl)-9-oxa-3,6-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),2,4,10,12-pentaen-12-yl)amino)propanamide
- (2S)-2-({2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)propanamide
- (2S)-2-({4-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-9-oxa-3,6-diazatricyclo[8.4.0.0(2),?]tetradeca-1(14),2,4,10,12-pentaen-12-yl}amino)propanamide
- (2S)-2-({4-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-9-oxa-3,6-diazatricyclo[8.4.0.0,tetradeca-1(14),2,4,10,12-pentaen-12-yl}amino)propanamide
- (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
- (S)-2-((2-((S)-4-(difluoromethyl)- 2-oxooxazolidin-3-yl)-5,6- dihydrobenzo[f]imidazo[1,2- d][1,4]oxazepin-9- yl)amino)propanamide
- (S)-2-((2-((S)-4-(Difluoromethyl)-2-oxooxaZolidin-3-yl)-5,6-dihydrobenZo[f]imidaZo[1,2-d][1,4]oxaZepin-9-yl)propanamide
- (S)-2-[[2-[(S)-4-(Difluoromethyl)-2-oxo-3-oxazolidinyl]-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]amino]propanamide
- Propanamide, 2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]-, (2S)-
- X3N